Brief: BrainsWay Reports Positive Results From Multicenter Randomized Study Of Accelerated Deep TMS For Major Depressive Disorder
11/06/2025 12:42
June 11 (Reuters) - Brainsway Ltd BWAY.TA: BRAINSWAY REPORTS POSITIVE RESULTS FROM MULTICENTER RANDOMIZED STUDY OF ACCELERATED DEEP TMS FOR MAJOR DEPRESSIVE DISORDER (MDD) BRAINSWAY LTD - ACCELERATED DEEP TMS PROTOCOL SHOWS COMPARABLE OUTCOMES TO STANDARD TMS BRAINSWAY LTD - ACCELERATED PROTOCOL WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS Source text: ID:nGNX6PkqTZ Further company coverage: BWAY.TA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)